Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Windfall allocation strategy for debt outlines a disciplined plan to direct windfall funds to the most impactful debts first.
21,046 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A growing wave of workers relies on AI to interpret messages and draft replies from supervisors, a trend that could s...
Immersed, a private VR work platform behind the work-from-VR trend, is closing its under-$1 retail round. Early metri...
Policymakers are weighing tax shifts that could touch luxury spending by the ultra-wealthy. Investors watch designer ...
At Consensus 2026 in Miami, Pi Network’s Dr. Chengdiao Fan laid out a vision for utility-driven tokens and real-world...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
A bizarre online listing claims a desk art piece tied to Epstein. This article explores the business case, ethics, an...
Intel has surged 116% in the past month as AI demand strengthens data-center demand and early talks of a potential Ap...
Step into the 2026 beauty health (skin) investing landscape. This guide translates early 2026 earnings signals into a...
Fresh analyst calls are steering the early-week mood on Wall Street. Dell Technologies, BioMarin, Disney, HubSpot and...
A crackdown powered by machine learning is changing how crypto exchanges protect you. Binance claims its AI-driven de...
Global oil inventories are near eight-year lows as tensions around Iran raise the risk of supply disruption. Prices h...